Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Mantingh

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
Prenatal Diagnosis|November 25, 1998
Schwangerschafts protein 1 (SP1) adds little to the age-related detection of fetal Down syndrome in the first trimester of pregnancyL H Kornman, L P Morssink, K A Ten Hoor, et al.
Early Human Development|December 30, 1996
The significance of placental pathology in pregnancies with unexplained abnormal concentrations of MSAFP or MShCGL P Morssink, B T de Wolf, L H Kornman, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|January 1, 1990
Children born after their fathers had been treated with chemotherapy for testicular cancerB M van der Kolk, N H Mulder, A Mantingh, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
Prenatal Diagnosis|November 25, 1998
Schwangerschafts protein 1 (SP1) adds little to the age-related detection of fetal Down syndrome in the first trimester of pregnancyL H Kornman, L P Morssink, K A Ten Hoor, et al.
Early Human Development|December 30, 1996
The significance of placental pathology in pregnancies with unexplained abnormal concentrations of MSAFP or MShCGL P Morssink, B T de Wolf, L H Kornman, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|January 1, 1990
Children born after their fathers had been treated with chemotherapy for testicular cancerB M van der Kolk, N H Mulder, A Mantingh, et al.
Pageof 6